Chen Jiaqi: Hong Kong Investment Company's investment return exceeded 2 billion Hong Kong dollars last year, with less than 20% of the funds already deployed.

The Hong Kong Investment Corporation revealed its investment performance for the first time three years after its establishment. Clara Chan, the CEO of the Hong Kong Investment Corporation, stated that benefiting from investments in initial public offerings (IPOs) and biotechnology companies, the corporation is expected to generate over HK$2 billion in investment returns by 2024. The corporation was established in 2022 with an initial investment fund of HK$62 billion, but as of the end of last year, less than 20% of the funds had been deployed. In addition to the initial HK$62 billion funding from the Hong Kong government, the corporation has also secured around HK$2.8 billion in new funds from a new capital investor plan. Chan mentioned that the investment speed and returns of the corporation are in line with the set targets, and there is a need to strike a balance between investment risks and investment speed. The current investment fund is entering its second stage, seeking regional partners such as sovereign wealth funds, retirement funds, and corporations for larger-scale investments. Meanwhile, investors from Southeast Asia and the Middle East have shown great interest in investing in Hong Kong companies. She further stated that the corporation plans to increase its investment efforts in a more systematic way in the coming year. Currently, the investment fund is diversified through four portfolios, covering 150 companies in industries such as technology and biotechnology. Chan believes that the future growth of the investment fund will mainly come from biotechnology companies, many of which are considering listing in Hong Kong or potential mergers and acquisitions. Two companies listed in Hong Kong have already brought returns of two to three times for the fund.